RVMD

Revolution Medicines Inc.

Price

$207.20

return (12m)

371.77%

p/e

-24.71

p/bv

16.77

DIVIDEND YIELD

0.00%

RVMD price

Revolution Medicines

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RVMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.48%

3 months

13.80%

1 year

371.77%

2 years

372.41%

5 years

595.77%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals RVMD

Valuation

P/E

-24.71

Sector -3.51

Industry -3.51

P/BV

16.77

Sector 1.99

Industry 1.99

P/Revenue (PSR)

Sector 2.05

Industry 2.05

EV/EBITDA

-65.81

Sector -215.71

Industry -215.71

EV/EBIT

-64.85

Sector -46.22

Industry -46.22

P/EBITDA

-25.91

Sector -21.18

Industry -21.18

P/EBIT

-25.57

Sector -28.19

Industry -28.19

P/Total Assets

10.11

Sector 1.18

Industry 1.18

P/Net Current Assets

18.91

Sector -10.00

Industry -10.00

P/Working Capital

11.89

Sector 1.60

Industry 1.60

EPS

-8.38

Sector -1.80

Industry -1.80

BVPS

12.36

Sector 2.03

Industry 2.03

Efficiency

Gross Margin

0.00%

Sector 41.43%

Industry 41.43%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,221,130.86%

Industry -4,221,130.86%

Operating Margin

0.00%

Sector -35.37%

Industry -35.37%

Net Profit Margins

0.00%

Sector -36.08%

Industry -36.08%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-67.85%

Sector -57.16%

Industry -57.16%

ROA

-40.90%

Sector -59.52%

Industry -59.52%

ROIC

-568.79%

Sector -2,363.38%

Industry -2,363.38%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

11.38

Sector 2.91

Industry 2.91

Net Debt / EBITDA

5.64

Sector -14,058,646.59

Industry -14,058,646.59

Net Debt / EBIT

5.56

Sector -8.05

Industry -8.05

Net Debt / Equity

-1.32

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.19

Sector 0.00

Industry 0.00

Equity/Assets

0.60

Sector 0.46

Industry 0.46

Liabilities/Assets

0.40

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

56.71%

Sector -

Industry -

Fundamentals RVMD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
RVMD Revolution Medicines Inc.	$207.20	375.88%	0.00%	-24.71	16.77	-67.85%	0.00%
JNJ Johnson & Johnson	$269.99	56.27%	1.96%	30.90	7.65	24.76%	21.48%
PFE Pfizer Inc.	$28.31	25.77%	6.08%	37.23	1.89	5.07%	6.80%
ABBV AbbVie Inc.	$263.16	23.44%	2.60%	73.78	-78.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.62	-27.65%	4.80%	9.44	5.02	53.11%	35.32%
MRK Merck & Co. Inc.	$147.79	92.78%	2.29%	114.37	8.64	7.56%	4.77%
AZN AstraZeneca PLC	$166.12	14.91%	1.95%	19.85	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.01	48.57%	4.09%	13.50	5.62	41.59%	18.87%
ZTS Zoetis Inc.	$69.90	-49.71%	2.99%	11.07	9.27	83.77%	27.69%
AMGN Amgen Inc.	$409.53	50.71%	2.43%	25.29	18.92	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$789.37	42.66%	0.47%	18.75	2.56	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$114.87	51.86%	0.00%	32.57	93.84	288.13%	24.86%
MCK McKesson Corporation	$863.15	14.07%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$521.52	38.47%	0.00%	30.03	6.53	21.76%	35.00%
CAH Cardinal Health Inc.	$220.60	44.54%	0.93%	30.18	-18.99	-62.92%	0.67%
ARGX argenx SE	$957.38	31.19%	0.00%	1.85	2.21	119.72%	44.81%
HRMY Harmony Biosciences Holdings Inc.	$41.02	53.29%	0.00%	13.11	2.38	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RVMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Revolution Medicines

Revolution Medicines Inc.

Average Investor10 user rating

4.0 (6 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

125

Employees

Revolution Medicines Inc. (United States) is listed on the Nasdaq and has a market capitalization of $43.70 billion, with shareholders equity totaling $2.61 billion.

The company employs approximately 125 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Revolution Medicines Inc. reported $- in revenue, generating net income of $-1.77 billion.

Key financial metrics include a P/E ratio of -24.71, a price-to-book (P/B) ratio of 16.77, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker RVMD.

Market cap

$43.70 billion

Net worth

$2.61 billion

$2,606,238,000.00

Assets

$4.32 billion

$4,323,270,000.00

Total Shares Outstanding

210.89 million

210,893,000

Average Daily Trading Volume

$1.92 million

$1,921,896.10

Sector

Health Care

Industry

Biotechnology

RVMD

RVMD revenue and profits

Financial Results RVMD

DRAG THE FRAME TO SEE MORE DATA

RVMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$863.15 14,07% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$220.60 45,03% (12M)

P/E

30.18

0.93%

ROE

-62.92%

P/BV

-18.99

JNJ - Johnson & Johnson

$269.99 53,64% (12M)

P/E

30.90

1.96%

ROE

24.76%

P/BV

7.65

ABBV - AbbVie

$263.16 23,09% (12M)

P/E

73.78

2.60%

ROE

-106.44%

P/BV

-78.53

MRK - Merck & Co.

$147.79 94,36% (12M)

P/E

114.37

2.29%

ROE

7.56%

P/BV

8.64

AZN - AstraZeneca

$166.12 13,98% (12M)

P/E

19.85

1.95%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$28.31 27,52% (12M)

P/E

37.23

6.08%

ROE

5.07%

P/BV

1.89

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$863.15 14,07% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$220.60 45,03% (12 M)

P/L

30.18

0.93%

ROE

-62.92%

P/VP

-18.99

JNJ - Johnson & Johnson

$269.99 53,64% (12 M)

P/L

30.90

1.96%

ROE

24.76%

P/VP

7.65

ABBV - AbbVie

$263.16 23,09% (12 M)

P/L

73.78

2.60%

ROE

-106.44%

P/VP

-78.53

MRK - Merck & Co.

$147.79 94,36% (12 M)

P/L

114.37

2.29%

ROE

7.56%

P/VP

8.64

AZN - AstraZeneca

$166.12 13,98% (12 M)

P/L

19.85

1.95%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$28.31 27,52% (12 M)

P/L

37.23

6.08%

ROE

5.07%

P/VP

1.89

Frequently Asked Questions

What is the price of Revolution Medicines (RVMD) today?

The current price of Revolution Medicines (RVMD) is $207.20. The stock began the year trading around $79.65 and is currently priced at $207.20. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Revolution Medicines (RVMD) pay dividends?

Revolution Medicines (RVMD) did not pay dividends over the past year.

Is Revolution Medicines (RVMD) a good investment?

Revolution Medicines (RVMD) is currently trading at $207.20 with a P/E ratio of -24.71. This represents a -1,373% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 371.77%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Revolution Medicines (RVMD) stock?

You can buy Revolution Medicines (RVMD) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RVMD and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Revolution Medicines (RVMD) yield today?

Over the past month, Revolution Medicines (RVMD) has returned 0.48% — 371.77% over the past year, and 595.77% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Revolution Medicines (RVMD) today at the current price of $207.20 your total investment would be $20,720.00.

Based on historical performance, the investment would have grown to approximately:

$97,750.74 after 1 year
$144,163.54 after 5 years
$20,720.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RVMD

Revolution Medicines Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RVMD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING RVMD WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Revolution Medicines

Revolution Medicines Inc.

United States

12 years

2020

125

PROFIT X PRICE RVMD

Financial Results RVMD

RVMD cash flow

Asset, Revenue and Profit Growth - RVMD

RVMD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions